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The persistence and transmission of infectious disease 
is one of the most enduring and daunting concerns in 
healthcare. Over the years, epidemiological analysis 
especially of bacterial etiological agents has under-
gone a remarkable evolutionary metamorphosis. While 
initially relying on purely phenotypic characterisation, 
advances in molecular biology have found transla-
tional application in a number of approaches to strain 
typing which commonly centre either on ‘epityping’ 
(molecular epidemiology) to characterise outbreaks, 
perform surveillance, and trace evolutionary path-
ways, or ‘pathotyping’ to compare strains based on 
the presence or absence of specific virulence or resist-
ance genes. A perspective overview of strain typing 
is presented here considering the issues surrounding 
analyses which are employed in the localised clinical 
setting as well as at a more regional/national public 
health level. The discussion especially considers the 
shortcomings inherent in epidemiological analysis: 
less than full isolate characterisation by the typing 
method and limitations imposed by the available data, 
context, and time constraints of the epidemiological 
investigation (i.e. the available epidemiological win-
dow). However, the promises outweigh the pitfalls as 
one considers the potential for advances in genomic 
characterisation and information technology to pro-
vide an unprecedented aggregate of epidemiological 
information and analysis.
Introduction
 Since the time of Semmelweis and Koch’s Postulates, 
medical science has recognised the cause-and-effect 
relationship between the transmission of etiological 
agents and the persistence and spread of infectious 
disease. In this context, routine clinical and infection 
control interests commonly centre on the detection of 
multifocal patient infection or dissemination within a 
defined patient population (e.g. outbreak identifica-
tion, control, or other rather short-term epidemiological 
issues). Conversely, public health concerns include 
local, regional, national, and international emergence 
and spread of pathogens, global microbiological and 
molecular surveillance, as well as longer term evolu-
tionary interrelationships. Classical epidemiology uses 
the three parameters (time, place, person) to find epi-
demiological links. However, in both healthcare and 
community-associated infections today, those three 
parameters do not necessarily provide the desired 
resolution to identify an outbreak event or the causing 
pathogen. Clinical microbiology provides species-level 
isolate identification and molecular analysis provides 
the strain type or subtype fingerprint. Bringing these 
five parameters together provides the greatest hope of 
associating outbreaks of infectious disease with cer-
tain types of the same bacterial species. This perspec-
tive overview considers the epidemiological analysis 
of infectious diseases in both the clinical and public 
health setting, focusing on bacterial etiologies to illus-
trate issues associated with moving molecular strain 
typing from theory to practical application. Regardless 
of the setting, the interrelationships that strain typing 
seeks to clarify are generally in the context of epityp-
ing (i.e. transmission investigation (e.g. outbreak)) or 
pathotyping to compare strains based on the presence 
or absence of specific virulence genes. The former 
is emphasised here and discussed in the context of 
two principal challenges independent of the methods 
employed: isolate characterisation and the available 
data, context, and time constraints of the epidemio-
logical investigation (i.e. the available epidemiological 
window).
The challenge of isolate characterisation
In both the clinical and public health setting, the 
assessment of potential interrelationships between 
isolates is based on a comparison of specific character-
istics which ideally will identify (i.e. fingerprint) trans-
mitted strains as the same type while not overlooking 
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epidemiologically relevant variants (subtypes) or mis-
takenly including unrelated isolates (i.e. issues of sen-
sitivity and specificity). Isolate characterisation has 
been historically based on phenotypic assessment 
which is most certainly still of value (e.g. antibiograms, 
serotyping). However, recognition of the bacterial chro-
mosome as the fundamental molecule of cellular iden-
tity has firmly established the importance of molecular 
(genomic) epidemiological evaluation. Thus, molecular 
approaches to isolate characterisation are considered 
here. In general, historical review reveals a consist-
ent ‘translational’ trend of genotypic methods moving 
from the basic science laboratory to clinical applica-
tion. These approaches to molecular epidemiology are 
reviewed more completely elsewhere [1,2] and are only 
summarised here to note the challenges faced in terms 
of providing definitive isolate characterisation for epi-
demiological purposes.
Simply stated, when it comes to epidemiological sen-
sitivity and specificity the key methodological issues 
are: (i) the degree to which the targets/markers being 
analysed provide epidemiologically relevant infor-
mation and (ii) the precision with which the queried 
characteristic(s) are identified and analysed. The for-
mer relates to epidemiological validation which has 
been considered elsewhere [3] and is beyond the scope 
of this discussion. However, by way of summary it is 
important to note that, regardless of analytical pre-
cision, other than whole genome sequencing (WGS) 
all methods strive to assess isolate interrelatedness 
based on a subset of targets that represent a genomi-
cally incomplete, but epidemiologically relevant, 
dataset. Thus, for these approaches, additional data 
is more informative than less (e.g. see [4]). In terms 
of precise data output, while newer methods employ 
instrumentation (e.g. capillary electrophoresis using 
an automated DNA sequencer [5]), a significant number 
of currently used protocols rely on visual inspection 
of data output generated by agarose gel electropho-
resis (Table). While such analysis can be accurate for 
protocols involving the presence or absence of end 
point polymerase chain reaction (PCR) products, vis-
ual assessment of fragment-size comparisons (e.g. by 
agarose gel electrophoresis) can be problematic. For 
example, digestion of total cellular DNA by common 
restriction enzymes (restriction endonuclease analysis 
(REA)) can generate greater than 600 fragments from 
a typical 2 to 3 Mb bacterial chromosome. In addition, 
there is an element of imprecision in the visual compar-
ison of DNA banding patterns in electrophoresis gels 
since DNA fragments differing by ±10% may be seen as 
identical [6]. This could amount to a 70 kb discrepancy, 
for example, in a pulsed-field gel with bands ca. 700 
kb in size.
As noted earlier, the chromosome is the most fun-
damental molecule of identity in the cell. Thus, it is 
the sequence-based methods that ultimately hold 
the greatest promise for accurately assessing epide-
miological interrelationships in problem pathogens. 
Reviewed elsewhere [2,7] these methods can be found 
in three general iterations: single locus sequence typ-
ing (SLST), multilocus sequence typing (MLST), and 
WGS (Table). Of these, the first two have found broad 
epidemiological application although, as noted above 
for other methods, both represent a genomically 
incomplete dataset, while WGS holds clear promise 
for providing total chromosomal analysis. While WGS 
was impossible with older dideoxy/chain termination 
sequencing technology [8], newer (i.e. next genera-
tion sequencing, NGS) methods have made this goal 
a reality. The technology behind NGS is discussed in 
detail elsewhere [7,9], however, from a strain typing 
Table 
Characteristics of methods commonly used for molecular epidemiology
Data generation Chromosomal target(s) Data output Method examples
Restriction enzymes Common restriction sites DNA fragments visualised after agarose gel 
electrophoresis (AGE)
Restriction endonuclease analysis 
(REA)
Restriction enzymes Common restriction sites Ordered sequence scaffolds identified via 
instrument software
Optical mapping




Repetitive element or 
variable-number tandem 
repeat (VNTR) sequences
Amplified DNA fragments either visualised after 
AGE or via instrument software
Repetitive-element PCR (rep-PCR); 
VNTR typing; 
PCR ribotyping
DNA probes Multiple genes Hybridisation signal either identified visually or 
via instrument software
Microarray
DNA sequencing Single or multiple genes DNA sequence obtained via instrument software Staphylococcus aureus protein 
A gene (spa) typing; multilocus 
sequence typing (MLST)
DNA sequencing Whole genome DNA sequence obtained via instrument software Whole genome sequencing (WGS); 
next generation sequencing (NGS)
A full description of methods is reported elsewhere [1,2].
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standpoint it is important to note that revolutionary 
developments in NGS have made WGS possible with 
benchtop instrumentation such as the Ion Torrent 
PGM (Life Technologies, Guilford), GS Junior (454 Life 
Sciences/Roche, Branford), and the MiSeq (Illumina, 
San Diego). Such instrumentation now allows WGS to 
be completed in hours to days with extensive multi-
fold coverage allowing isolates to be compared down 
to the level of single nucleotide polymorphisms (SNPs). 
However, as with previous sequencing iterations, the 
critical issues for NGS are throughput, quality, read 
length and cost. All of these are currently in a state 
of flux as commercial technology improves and posi-
tions itself in the scientific marketplace. In addition, it 
must be noted that the present state of WGS has not 
reached accurate base-by-base total origin-to-termini 
output. For example, the assembly and analysis of the 
relatively short read lengths from current NGS plat-
forms are problematic for repeat sequences (e.g. clus-
tered regularly interspaced short palindromic repeats 
(CRISPRs), homopolymers, and variable-number tan-
dem repeats (VNTRs) [10]). An additional bottleneck is 
the bioinformatics requirement for proper WGS annota-
tion and analysis which at present is far from routine, 
with costs (in time and money) that may exceed that 
of the sequencing itself [11,12]. Nevertheless, these are 
exciting ‘problems’ to have, confirming that the scien-
tific stage is clearly set for remarkable developments 
in this most fundamental approach to determining iso-
late epidemiological interrelationships.
The challenge of the epidemiological 
window and detecting significant difference
Regardless of the epidemiological approach, the 
focus ultimately becomes data interpretation. Thus, 
it is important to note that while the term ‘molecular’ 
epidemiology implies a precise process, this is not 
always the case regardless of the method employed 
since epidemiological analysis always has an unavoid-
able context and time-driven component. A variety of 
environmental factors as well as interaction between 
the host and infectious agent may all influence the 
course of disease transmission. In addition, the time 
leading up to, as well as that required for, the epide-
miological investigation provides opportunity for the 
outbreak strain to evolve. Whether in a clinical or pub-
lic health setting, infectious disease scenarios benefit-
ing from epidemiological evaluation do not typically 
give advance warning. Hence, in many investigations 
where the starting point of the epidemiological sce-
nario (e.g. the source case or the outbreak source) is 
not identified, the process of data analysis attempts 
to work backward in time which, depending on the 
available information, may necessitate drawing conclu-
sions based on probabilities rather than absolute cer-
tainty [13]. However, as with classical epidemiological 
approaches, molecular epidemiological analysis may 
to some extent implicate the source ‘beyond a reason-
able doubt’. 
In the absence of a source isolate, all strain typing 
methods are challenged as the opportunity for chro-
mosomal change over time increases the potential for 
genetic distance between epidemiologically related 
isolates (i.e. confounding the recognition of interre-
lationships in the isolates being analysed). This can 
be illustrated (Figure) considering a simple example 
of six epidemiologically-relevant characters (‘A’) in a 
reference genome (e.g. the characters could be restric-
tion sites, specific genes, other chromosomal loci). 
Evolution through two generations, with sequential 
genetic events of unknown complexity (e.g. insertions, 
deletions, rearrangements, recombination) designated 
as changes from ‘A’ to ’B’, results in second-generation 
genomes varying from each other by four differences. 
As the process continues through subsequent gen-
erations additional complexity in the population dra-
matically increases. This scenario illustrates the issue 
central to the interpretation of any bacterial strain typ-
ing data, the definition and detection of significant 
difference. This relates to the issues of sensitivity and 
specificity previously addressed, in particular specific-
ity, which is important to insure adequate case defi-
nitions for outbreak investigations, in order to avoid 
inclusion of non-cases and detect maximum epide-
miological associations between the isolates. Thus, 
for optimum epidemiological outcome, proper analy-
sis of strain typing data requires knowledge of: (i) the 
genetics of the microbial pathogen (e.g. clock speed/
rate of change of the characteristics being analysed), 
(ii) the limitations of the typing method, (iii) the degree 
of concordance between different typing methods, if 
more than one technique is applied in parallel, and 
(iv) the setting within which the issue is being studied. 
Regardless of the typing approach, these details must 
be considered in attempting to discern the relatedness 
and transmission patterns of infectious agents in both 
the clinical and public health setting.
Figure
Diagrammatic illustration of interrelationships between a 
reference genome and two subsequent generations each of 















Reference genome                      Generation 1                           Generation 2
The reference genome has six epidemiologically-relevant 
characteristics (designated ‘A’). Each generation differs from the 
previous by a single genetic event (indicated by the number 1 
above the horizontal arrows) changing characteristics from A to B. 
For each generation, the numbers of genetic differences between 




It is of utmost importance, that typing methods pro-
duce data that can be compared not only within the 
same laboratory or clinical setting, but also between 
different facilities. Therefore, the ‘typing Esperanto’ 
or language should produce data that are clear, repro-
ducible, and include strain nomenclature which allows 
for the independent identification of specific types. 
However, it is important to note that the probability of 
an outbreak due to a certain strain type depends on 
its frequency in the associated environment (e.g. both 
within and outside of the healthcare setting, the com-
munity). The less frequent a strain type is, the more 
probable it becomes that multiple isolates (a cluster) of 
a certain strain type represent a true outbreak. Thus, 
epidemiological analysis must recognise the nuances 
associated with disease transmission such as distin-
guishing outbreaks from pseudo-outbreaks [14]. The 
latter occur frequently in environments associated with 
an endemic prevalence of antibiotic-resistant microor-
ganisms. For example, in a clinical setting, patients on 
the same hospital ward may carry similar but distinct 
problem pathogens which could superficially mimic an 
outbreak. Useful typing should properly identify such 
a pseudo-outbreak thus helping to avoid inappropri-
ate escalation of ‘outbreak’ management. This kind 
of ‘de-compromising’ and ‘de-escalating’is one of the 
major reasons why local hospitals and their laborato-
ries perform strain typing for outbreak analysis. Thus, 
whether in a clinical or public health setting, the dis-
criminatory or resolving power of a given epidemio-
logical analysis is not solely dependent on a method 
or a method-pathogen combination but may be also be 
influenced by the pathogens’ diversity (i.e. the more or 
less frequent appearance/epidemicity or endemicity of 
a specific type).
Choosing the ‘best’ method for typing
Whether considering strain typing from the clinical or 
public health perspective, the logical question is: what 
is the best method procedurally to use? However, there 
are a number of reasons why a ‘one size fits all’ answer 
to this question is impractical.
Considering first the clinical environment, as noted 
earlier, strain typing is commonly of value in assess-
ing therapeutic concerns such as multisite infection 
or emergence of antimicrobial resistance in the indi-
vidual patient, and transmission of problem pathogens 
within a limited patient population (e.g. a healthcare 
or family unit). In this context the key issues include: 
(i) having the required technical expertise, (ii) poten-
tial for automation/routine applicability, (iii) cost, (iv) 
required time-to-answer, (v) equipment maintenance 
and footprint size, (vi) intuitive data output and objec-
tive, standardisable, or automated interpretation, (vii) 
relevance of the typing result for further investigations 
(e.g. screening of staff) or for reporting to public health 
authorities. 
It is logical to aspire to the most recently published 
cutting-edge method. However, the newest iteration of 
the most sophisticated and advanced technology is of 
little value if one does not have physical room for it, 
cannot afford it, properly operate it, or readily achieve 
clinically or epidemiologically relevant outcomes from 
the data generated. While one would never recommend 
gravitating to the lowest technological denominator 
for strain typing, to a large extent the ‘best’ method 
in a given clinical environment depends on the avail-
able resources addressing the issues noted above. In 
this context, as stated earlier, it is important to rec-
ognise that, regardless of sophistication, molecular 
strain typing commonly operates from an incomplete 
data set since all relevant clinical isolates may not be 
available and all isolate characteristics may not have 
been analysed, although the latter issue will be less of 
a concern in the future as WGS becomes more refined 
and widespread. In addition, communication between 
appropriate clinical interests (e.g. physician, labora-
tory, nursing, infection control) is vital to putting the 
‘incomplete’typing data into the fullest context for a 
meaningful outcome in terms of infection prevention 
and control. 
Taken together, in addition to routine and real time 
strain typing, key elements for successful strain typing 
in the clinical setting most certainly include [3,15]: (i) 
initiation of strain typing by the hospital epidemiolo-
gist in consultation with infection control, infectious 
disease, and microbiology personnel, (ii) targeting 
of strain typing to investigate specific infectious dis-
ease issues such as an unusual increase in the rate 
of isolation of a pathogen, a cluster of infections in a 
particular healthcare unit, and multiple isolates with 
unusual (e.g. antibiotic susceptibility) characteristics, 
(iii) understanding that strain typing in the absence 
of epidemiological context and follow-up is an ineffi-
cient use of laboratory resources. Strain typing should 
supplement, not replace, careful epidemiological 
investigation.
To a large extent, the issues affecting approaches to 
strain typing for public health purposes are similar 
to those previously noted for local clinical efforts. 
However, there are important differences. The con-
cerns of public health, while clinical in nature, are 
much broader in scope especially focusing on the 
transmission of problem pathogens on a local, 
regional, national, and international scale. Therefore, 
while financial and technical resources are gener-
ally more abundant at the regional/national level, the 
complexity of the necessary outcomes is greater as 
well. Effective communication to insure that the typing 
method’s results are comparable between all labora-
tories involved is at the heart of a proper large-scale 
understanding of infectious disease occurrence and 
transmission. Everything from choice of typing method 
to data output and interpretation revolves around this 
issue. Thus, from a methodological standpoint the 
strain typing approach should: (i) be as standardised 
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as possible to be performed with similar efficiency, 
accuracy, and reproducibility in different participating 
laboratories, (ii) generate output that can be efficiently 
databased and shared, with interpretative criteria as 
objective as possible and a common terminology for 
strain type and subtype designations.
In this regard, sequence-based approaches hold the 
greatest promise. For example, SLST of the staphylococ-
cal protein A gene (spa-typing) is effectively used in the 
epidemiological monitoring of specific Staphylococcus 
aureus strains (i.e. SeqNet; www.seqnet.org) with 540 
laboratories from 51 countries submitting strains from 
90 countries worldwide using the Ridom spa server as a 
common platform [16]. As noted earlier, approaches to 
WGS are rapidly being developed and refined with the 
potential to ultimately provide strain typing data rang-
ing from key gene subsets [17] to total chromosomal 
comparison [18]. However, the success of the Pulse-
Net System, designed by the United States Centers for 
Disease Control to investigate food-borne outbreaks 
[19], as well as refinements in VNTR-based analysis of 
pathogens such as meticillin-resistant S. aureus [5,20], 
illustrate that older molecular typing approaches also 
have potential for effective public health application. 
Clinical and public health strain 
typing in perspective
Whether performed in a local clinical or more regional/
national public health setting, the effective use of 
strain typing requires an understanding of both the 
pitfalls and the promises of the process. While the 
pitfalls can certainly be methodological, perhaps the 
most fundamental caveat, as noted above, is that 
strain typing is not a standalone method. Therefore, 
more information and communication is better than 
less. The scenario is not unlike an unfolding mystery 
story where one needs as much evidence as possible 
to figure out who ‘did it.’ For both local and larger-scale 
regional settings, the promise is a better understand-
ing of the dynamics of infectious disease transmission 
with the hope of effective intervention (prevention, 
infection control, and treatment). Remarkable pos-
sibilities are on the horizon when one considers 
advances in genomic characterisation and the power 
of the Internet to facilitate the linking of strain typing 
analysis and databasing to other previously disparate 
data such as antimicrobial resistance (e.g. European 
Antimicrobial Resistance Surveillance Network (EARS-
Net); www.ecdc.europa.eu/en/activities/surveillance/
EARS-Net/Pages/index.aspx) and geographic informa-
tion systems (GIS) as elegantly shown by the European 
Staphylococcal Reference Laboratory (SRL) working 
group (www.spatialepidemiology.net/srl-maps)[21] 
EpiScanGIS (www.episcangis.org), Global Network for 
Geospatial Health (GnosisGIS) (www.gnosisgis.org), 
and the World Health Organization (WHO)’s Public 
Health Mapping GIS effort (www.who.int/health_map-
ping/en). Most recently, during the Escherichia coli 
O104:H4 outbreak in Germany, open-source genomic 
analysis, available hardware/software resources and 
international expertise contributed tremendously to 
the rapid understanding of the pathogens’ evolution, 
dissemination, and pathology [22]. Thus, for the future, 
the promises outweigh the pitfalls as molecular strain 
typing seeks to address enduring infectious disease 
issues with important morbidity, mortality, economic, 
and general quality of life implications.
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